Article Details

Prothena Announces Achievement of $60 Million Milestone From Roche for First Patient Dosed in ...

Retrieved on: 2021-05-10 20:03:45

Tags for this article:

Click the tags to see associated articles and topics

Prothena Announces Achievement of $60 Million Milestone From Roche for First Patient Dosed in .... View article details on hiswai:

Excerpt

Roche's advancement of prasinezumab into this Phase 2b PADOVA study is an important step forward for this first-in-class compound, with the potential ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up